A novel use of (s)-adenosyl-l-methionine (same)

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/70 (2006.01)

Patent

CA 2216854

The use of SAMe and its physiologically acceptable salts in doses of over 2000 mg per day and patient for the parenteral treatment of conditions triggered by focal permanent ischaemia.

L'invention concerne l'utilisation de SAMe et de ses sels physiologiquement tolérables dans des doses supérieures à 2000 mg par jour et par patient, dans le traitement par voie parentérale de troubles dus à une ischémie permanente focale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A novel use of (s)-adenosyl-l-methionine (same) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A novel use of (s)-adenosyl-l-methionine (same), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A novel use of (s)-adenosyl-l-methionine (same) will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1583424

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.